爱游戏平台注册登录
check quantity

Unconjugated AlphaPlex™ 645 Acceptor Beads, 5 mg

Unconjugated AlphaPlex 645 (Samarium) Acceptor beads bear reactive aldehyde groups at their surface, allowing you to conjugate a wide variety of reagents using a simple reductive amination protocol.

For research use only; not for diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption & disposal requirements under European REACH regulations (EC 1907/2006).

Part Number
Unit Size
List Price
Your Price
Quantity
6792001
1 mg
2014.00 USD
 
more
6792002
5 mg
7100.00 USD
 
more
6792003
50 mg
42300.00 USD
 
more
爱游戏平台注册登录 Life Sciences & Diagnostics is now Revvity, but at this time, there is no change to the supplier information.
Request Technical Support

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

Unconjugated AlphaPlex 645 (Samarium) Acceptor beads bear reactive aldehyde groups at their surface, allowing you to conjugate a wide variety of reagents using a simple reductive amination protocol. AlphaPlex is a multiplexing no-wash ELISA alternative and can be used for applications such as:

  • Analyte detection
  • Protein-protein interactions
  • Protein-DNA interactions
  • Protein-RNA interactions
  • Protein-small molecule interactions
  • Protein detection assays
  • Antibody detection assays
  • Antibody binding
  • Immunogenicity assays
  • Enzymatic assays
  • Other immunoassays

AlphaPlex Acceptor beads are intended to be used in multiplexing assays, in conjunction with AlphaLISA Acceptor beads and Alpha Donor beads. In a typical Alpha assay, 1 mg of Acceptor beads is sufficient to run 1,000-2,000 wells using a 50 µL reaction volume.

Specifications

Antibody Conjugates Unconjugated
Automation Compatible Yes
Product Brand Name AlphaPlex
Shipping Condition Blue Ice
Unit Size 5 mg
Resources, Events & More
  • All

Application Brief

Eight Limitations of ELISA and How to Overcome Them Using Alternative Technologies

The introduction of enzyme-linked immunosorbent assays (ELISAs) in the early 1970’s offered researchers a non-radiometric immunoassay platform without compromising sensitivity. Over the last 50 years scientists have made huge strides in disease research and drug discovery and a demand for greater ...

PDF 1 MB

Application Note

Development of Pharmacokinetic (PK) Assays for Detecting Biosimilars Targeting TNF alpha using AlphaLISA

Anti-inflammatory monoclonal antibody drugs that specifically target TNFα, such as Humira®, have been highly successful in the market. As patents expire on these top-selling drugs, effort has been placed on developing biosimilars. Biosimilars differ from small molecule generi ...

PDF 2 MB

Brochure

Baidu
map